Skip to main content

ADVERTISEMENT

Lajos Pusztai, MD, DPhil

Lajos Pusztai, MD, DPhil
Conference Coverage
01/03/2024
Lajos Pusztai, MD, DPhil, discussed results from the DARE study which analyzed the clinical utility of ctDNA monitoring during adjuvant endocrine therapy to detect molecular relapse before apparent recurrence.
Lajos Pusztai, MD, DPhil, discussed results from the DARE study which analyzed the clinical utility of ctDNA monitoring during adjuvant endocrine therapy to detect molecular relapse before apparent recurrence.
Lajos Pusztai, MD, DPhil,...
01/03/2024
Oncology